How MDNA’s mitochondrial markers could diagnose diseases earlier
MDNA Life Sciences Inc. thinks circulating mitochondrial DNA holds the key to early, non-invasive detection of a host of diseases. Having launched its first mitochondrial-based diagnostic in October - a prostate cancer blood test dubbed Prostate Mitomic Test - the company is pushing ahead with a suite of mitochondrial biomarkers for a variety of cancers and other diseases. Next up is endometriosis.
MDNA CEO Christopher Mitton told BioCentury that endometriosis is a